INS and type 2 diabetes mellitus: Together, these results indicate that chronic imeglimin treatment improves glucose tolerance and amplifies glucose‐stimulated insulin secretion in this extreme male ZDF rat model of T2D with marked hyperglycaemia (20.1 mmol/L).